The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma

Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established. We conducted a retrospective study of multiple myeloma comparing MYC SV su...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2021-10, Vol.27 (19), p.5430-5439
Main Authors: Sharma, Neeraj, Smadbeck, James B, Abdallah, Nadine, Zepeda-Mendoza, Cinthya, Binder, Moritz, Pearce, Kathryn E, Asmann, Yan W, Peterson, Jess F, Ketterling, Rhett P, Greipp, Patricia T, Bergsagel, P Leif, Rajkumar, S Vincent, Kumar, Shaji K, Baughn, Linda B
Format: Article
Language:English
Subjects:
Genes, myc
High-Throughput Nucleotide Sequencing
Humans
Immunoglobulins - genetics
Multiple Myeloma - diagnosis
Multiple Myeloma - genetics
Prognosis
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established. We conducted a retrospective study of multiple myeloma comparing MYC SV subtypes identified by next-generation sequencing (NGS) and FISH to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study. MYC SVs were found in 41% of cases and were classified into nine subtypes. A correlation between the presence of a MYC SV and increased MYC expression was identified. Among the nine MYC subtypes, the non-immunoglobulin (non-Ig) insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared with other MYC SV subtypes. Although the FISH methodology failed to detect approximately 70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared with other MYC subtypes. Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in multiple myeloma. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone.
ISSN:1078-0432
1557-3265
DOI:10.1158/1078-0432.CCR-21-0005